123 related articles for article (PubMed ID: 36946410)
1. Autotaxin is a novel surrogate marker for oxaliplatin-related sinusoidal obstruction syndrome in patients with colorectal liver metastasis.
Ishii N; Harimoto N; Seki T; Muranushi R; Hagiwara K; Tsukagoshi M; Watanabe A; Yoshida Y; Araki K; Shirabe K
Hepatol Res; 2023 Aug; 53(8):761-770. PubMed ID: 36946410
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
Stevenson HL; Prats MM; Sasatomi E
BMC Cancer; 2017 Jan; 17(1):35. PubMed ID: 28061766
[TBL] [Abstract][Full Text] [Related]
3. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O
Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model.
Robinson SM; Mann J; Vasilaki A; Mathers J; Burt AD; Oakley F; White SA; Mann DA
J Hepatol; 2013 Aug; 59(2):318-26. PubMed ID: 23624001
[TBL] [Abstract][Full Text] [Related]
5. Clinically relevant model of oxaliplatin-induced sinusoidal obstruction syndrome.
Toda R; Seo S; Uemoto Y; Morino K; Nishino H; Nakamura N; Okuno M; Iguchi K; Sato M; Nakamura K; Taura K; Nakagawa S; Nakagawa T; Tsuruyama T; Manabe T; Kawaguchi H; Iwaisako K; Ikegawa M; Uemoto S; Hatano E
Hepatol Res; 2023 Feb; 53(2):145-159. PubMed ID: 36149410
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation.
Cayet S; Pasco J; Dujardin F; Besson M; Orain I; De Muret A; Miquelestorena-Standley E; Thiery J; Genet T; Le Bayon AG
Eur J Radiol; 2017 Sep; 94():180-190. PubMed ID: 28712693
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Volume Fraction Calculated Using Contrast-Enhanced Computed Tomography as a Biomarker of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome: A Preliminary Histopathological Analysis.
Kai K; Hamada T; Sato Y; Hiyoshi M; Imamura N; Yano K; Ikeda T; Ichihara A; Ogata S; Choijookhuu N; Hishikawa Y; Hosokawa A; Nanashima A
J Oncol; 2023; 2023():1440257. PubMed ID: 36824665
[TBL] [Abstract][Full Text] [Related]
8. Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM - Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor.
Martins J; Alexandrino H; Oliveira R; Cipriano MA; Falcão D; Ferreira L; Martins R; Serôdio M; Martins M; Tralhão JG; Prado e Castro L; Castro E Sousa F
Eur J Surg Oncol; 2016 May; 42(5):713-21. PubMed ID: 26972374
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastases.
van den Broek MA; Vreuls CP; Winstanley A; Jansen RL; van Bijnen AA; Dello SA; Bemelmans MH; Dejong CH; Driessen A; Olde Damink SW
Ann Surg Oncol; 2013 May; 20(5):1462-9. PubMed ID: 23463086
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin-Induced Sinusoidal Obstruction Syndrome Masquerading as Colorectal Liver Metastasis: A Case Report.
Gupta V; Chopde A; Patkar S; Deodhar K; Goel M
J Gastrointest Cancer; 2023 Jun; 54(2):682-686. PubMed ID: 35666356
[TBL] [Abstract][Full Text] [Related]
11. Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome.
Sugita H; Nakanuma S; Munesue S; Ishikawa T; Tokoro T; Takei R; Okazaki M; Kato K; Takada S; Makino I; Ozaki N; Yamamoto Y; Yagi S
J Gastroenterol Hepatol; 2024 Feb; ():. PubMed ID: 38348885
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and management of hepatic injury induced by oxaliplatin-based chemotherapy in patients with hepatic resection for colorectal liver metastasis.
Morine Y; Shimada M; Utsunomiya T
Hepatol Res; 2014 Jan; 44(1):59-69. PubMed ID: 23551330
[TBL] [Abstract][Full Text] [Related]
13. Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab.
Hubert C; Sempoux C; Humblet Y; van den Eynde M; Zech F; Leclercq I; Gigot JF
HPB (Oxford); 2013 Nov; 15(11):858-64. PubMed ID: 23458554
[TBL] [Abstract][Full Text] [Related]
14. Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization.
Narita M; Oussoultzoglou E; Chenard MP; Rosso E; Casnedi S; Pessaux P; Bachellier P; Jaeck D
Surg Today; 2011 Jan; 41(1):7-17. PubMed ID: 21191686
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of collateral vessel development induced by oxaliplatin-based chemotherapy.
Mukai K; Nishida T; Matsumoto K; Kitanaka T; Hosokawa K; Sakamoto N; Okabe S; Fujii Y; Osugi N; Sugimoto A; Nakamatsu D; Yamamoto M; Fukui K
Int J Clin Oncol; 2023 Feb; 28(2):280-288. PubMed ID: 36586029
[TBL] [Abstract][Full Text] [Related]
16. Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization.
Narita M; Oussoultzoglou E; Chenard MP; Fuchshuber P; Rather M; Rosso E; Addeo P; Jaeck D; Bachellier P
Ann Surg Oncol; 2012 Jul; 19(7):2230-7. PubMed ID: 22402811
[TBL] [Abstract][Full Text] [Related]
17. Significance of postoperative adjuvant chemotherapy with an oxaliplatin-based regimen after simultaneous curative resection for colorectal cancer and synchronous colorectal liver metastasis: a propensity score matching analysis.
Sugimoto K; Sakamoto K; Ii Y; Amemiya K; Sugo H; Ito T; Munakata S; Takahashi M; Kojima Y; Tomiki Y; Sato K; Saiura A; Kawasaki S
BMC Surg; 2021 Apr; 21(1):188. PubMed ID: 33836701
[TBL] [Abstract][Full Text] [Related]
18. The influence of chemotherapy-associated sinusoidal dilatation on short-term outcome after partial hepatectomy for colorectal liver metastases: A systematic review with meta-analysis.
van Mierlo KM; Zhao J; Kleijnen J; Rensen SS; Schaap FG; Dejong CH; Olde Damink SW
Surg Oncol; 2016 Sep; 25(3):298-307. PubMed ID: 27566036
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin-based chemotherapy induces extravasated platelet aggregation in the liver.
Tajima H; Ohta T; Miyashita T; Nakanuma S; Matoba M; Miyata T; Sakai S; Okamoto K; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Inokuchi M; Nakagawara H; Takamura H; Kitagawa H; Fushida S; Ikeda H
Mol Clin Oncol; 2015 May; 3(3):555-558. PubMed ID: 26137266
[TBL] [Abstract][Full Text] [Related]
20. Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
Morris-Stiff G; White AD; Gomez D; Cameron IC; Farid S; Toogood GJ; Lodge JP; Prasad KR
Eur J Surg Oncol; 2014 Aug; 40(8):1016-20. PubMed ID: 24370284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
